Development and validation of a multimodality radiomics-based nomogram for predicting HER2 expression status in invasive breast cancer - Quiz - MDSpire

Development and validation of a multimodality radiomics-based nomogram for predicting HER2 expression status in invasive breast cancer

  • By

  • Xianwei Yang

  • Xiaoling Liu

  • Shenghong Wan

  • Yilin Luo

  • Mengjun Shen

  • Xin Liao

  • July 14, 2026

Share

Original Source(s)

Development and validation of a multimodality radiomics-based nomogram for predicting HER2 expression status in invasive breast cancer

  • by Xianwei Yang, Xiaoling Liu, Shenghong Wan, Yilin Luo, Mengjun Shen, Xin Liao

  • July 14, 2026

Related Content

Metastatic malignant melanoma presenting as bilateral acute mastitis in a lactating woman: a case report and literature review

Subtype-specific sonographic signatures and clinicopathological features of metaplastic breast cancer: a 50-case cohort study

Risk factors for radiation pneumonitis following adjuvant radiotherapy for breast cancer: a retrospective cohort study